Prostate International

Papers
(The H4-Index of Prostate International is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Oncological outcomes after radical prostatectomy of localized prostate cancer: stratified by magnetic resonance imaging and risk classification50
Does androgenic alopecia aggravate the risk of prostate cancer? Evidence from Mendelian randomization33
The association between behavioral habits and physical health status in prostate cancer patients: a large US national health-related survey20
Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer19
Association between pelvic lymph node dissection and survival among patients with prostate cancer treated with radical prostatectomy18
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer18
Is antibiotic prophylaxis still mandatory for transperineal prostate biopsy? Results of a comparative study17
Association between preradiation therapy prostate-specific antigen levels and radiation therapy failure after prostatectomy: a propensity score matched analysis16
Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship16
Therapeutic potentials of curcumin in prostate cancer: a comprehensive review of pathways and clinical prospects16
Treatment outcomes with radium-223 in patients with metastatic castration-resistant prostate cancer with bone metastasis in real-world practice: a multiinstitutional study16
Holmium laser enucleation of the prostate as a treatment option for patients with concurrent outlet obstruction and bladder diverticulum15
Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign 14
Safety and efficacy of extracorporeal shockwave therapy on chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled study14
0.021655082702637